EyePoint Pharmaceuticals, Inc. Sales Agreements
2 Contracts & Agreements
- Controlled Equity OfferingSM Sales Agreement, dated August 5, 2020, by and between EyePoint Pharmaceuticals, Inc. and Cantor Fitzgerald & Co (Filed With SEC on August 5, 2020)
- At Market Issuance Sales Agreement, dated January 18, 2019, between EyePoint Pharmaceuticals, Inc. and B. Riley FBR, Inc (Filed With SEC on January 18, 2019)
